Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Bio-technology

GRAINS-WHEAT/(INSIGHT)
RTSED2CJ 
December 21, 2022 
Five by 15 foot test plots of different hybrid wheat strains are grown at the research farm for the bio-technology... 
JUNCTION CITY, UNITED STATES 
Plots of hybrid wheat grows at the research farm for the bio-technology company Syngenta near Junction... 
Five by 15 foot test plots of different hybrid wheat strains are grown at the research farm for the bio-technology company Syngenta near Junction City, Kansas, U.S. May 4, 2017. REUTERS/Dave Kaup 
GRAINS-WHEAT/(INSIGHT)
RTSED2CG 
December 21, 2022 
An old barn is surrounded by hybrid wheat test plots outside the bio-technology company Syngenta's research... 
JUNCTION CITY, UNITED STATES 
Old barn and new wheat strains at the bio-technology company Syngenta near Junction City 
An old barn is surrounded by hybrid wheat test plots outside the bio-technology company Syngenta's research farm near Junction City, Kansas, U.S. May 4, 2017. REUTERS/Dave Kaup 
HIROTSUBIO-CANCER/WORMS
RTSDO4NC 
November 28, 2022 
Nematodes are seen on a monitor connected to a microscope during a photo opportunity at the lab of Hirotsu... 
FUJISAWA, Japan 
Nematodes are seen on a monitor connected to a microscope during a photo opportunity at the lab of Hirotsu... 
Nematodes are seen on a monitor connected to a microscope during a photo opportunity at the lab of Hirotsu Bio Science in Fujisawa, Kanagawa Prefecture, Japan November 28, 2022. REUTERS/Kim Kyung-Hoon 
HIROTSUBIO-CANCER/WORMS
RTSDO4N7 
November 28, 2022 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during... 
FUJISAWA, Japan 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during... 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during a photo opportunity at the company's lab in Fujisawa, Kanagawa Prefecture, Japan November 28, 2022. REUTERS/Kim Kyung-Hoon 
HIROTSUBIO-CANCER/WORMS
RTSDO4N6 
November 28, 2022 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during... 
FUJISAWA, Japan 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during... 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during a photo opportunity at the company's lab in Fujisawa, Kanagawa Prefecture, Japan November 28, 2022. REUTERS/Kim Kyung-Hoon 
HIROTSUBIO-CANCER/WORMS
RTSDO4JL 
November 28, 2022 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during... 
FUJISAWA, Japan 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during... 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio examines nematodes in a petri dish during a photo opportunity at the company's lab in Fujisawa, Kanagawa Prefecture, Japan November 28, 2022. REUTERS/Kim Kyung-Hoon 
HIROTSUBIO-CANCER/WORMS
RTSDO4JN 
November 28, 2022 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio points at nematodes on a monitor connected... 
FUJISAWA, Japan 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio points at nematodes on a monitor connected... 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio points at nematodes on a monitor connected to a microscope during a photo opportunity at the company's lab in Fujisawa, Kanagawa Prefecture, Japan November 28, 2022. REUTERS/Kim Kyung-Hoon 
HIROTSUBIO-CANCER/WORMS
RTSDO4JP 
November 28, 2022 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio poses with nematodes in a petri dish during... 
FUJISAWA, Japan 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio poses with nematodes in a petri dish during... 
Hirotsu Bio Science Chief Technical Officer Eric Di Luccio poses with nematodes in a petri dish during a photo opportunity at the company's lab in Fujisawa, Kanagawa Prefecture, Japan November 28, 2022. REUTERS/Kim Kyung-Hoon 
HEALTH-CORONAVIRUS/GERMANY-PHARMACIES
RTS58WT7 
February 07, 2022 
Pharmacist Thomas Stephan vaccinates a man with a dose of the Pfizer-BioNTech COVID-19 vaccine on the... 
Dusseldorf, Germany 
COVID-19 vaccinations in pharmacies in Dusseldorf 
Pharmacist Thomas Stephan vaccinates a man with a dose of the Pfizer-BioNTech COVID-19 vaccine on the first day trained pharmacies carry out COVID-19 vaccinations in the 'Europa Apotheke' pharmacy amid the corovavirus disease pandemic in Dusseldorf, Germany, February 7, 2022. REUTERS/Thilo Schmuelgen 
HEALTH-CORONAVIRUS/GERMANY-PHARMACIES
RTS58WT5 
February 07, 2022 
Pharmacist Thomas Stephan vaccinates a man with a dose of the Pfizer-BioNTech COVID-19 vaccine on the... 
Dusseldorf, Germany 
COVID-19 vaccinations in pharmacies in Dusseldorf 
Pharmacist Thomas Stephan vaccinates a man with a dose of the Pfizer-BioNTech COVID-19 vaccine on the first day trained pharmacies carry out COVID-19 vaccinations in the 'Europa Apotheke' pharmacy amid the corovavirus disease pandemic in Dusseldorf, Germany, February 7, 2022. REUTERS/Thilo Schmuelgen 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FP1D 
January 11, 2022 
Tomas Lara, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Tomas Lara, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FOZS 
January 11, 2022 
Tatiana Perez, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Tatiana Perez, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FOZW 
January 11, 2022 
Julian Parra, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Julian Parra, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FOXB 
January 11, 2022 
Fiorella Lopez, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Fiorella Lopez, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FOX7 
January 11, 2022 
Children, accompanied by their mothers, wait for a dose of the Pfizer-BioNTech coronavirus disease (COVID-19)... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Children, accompanied by their mothers, wait for a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FOUU 
January 11, 2022 
Parents and their children queue to enter a vaccination center to receive a dose of the Pfizer-BioNTech... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Parents and their children queue to enter a vaccination center to receive a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
HEALTH-CORONAVIRUS/COSTA RICA-VACCINATION
RTS4FORY 
January 11, 2022 
Emma Sevilla, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a... 
San Jose, Costa Rica 
Children get vaccinated against COVID-19 in San Jose 
Emma Sevilla, 11, receives a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center in San Jose, Costa Rica January 11, 2022. REUTERS/Mayela Lopez 
TECH-CES/
RTS4AN3Q 
January 06, 2022 
Robert Ford, president and CEO of Abbott Laboratories, talks about the company’s Lingo brand of bio-wearable... 
Las Vegas, UNITED STATES 
CES 2022 in Las Vegas 
Robert Ford, president and CEO of Abbott Laboratories, talks about the company’s Lingo brand of bio-wearable devices during a keynote address at CES 2022 in Las Vegas, Nevada, U.S. January 6, 2022. REUTERS/Steve Marcus 
TECH-CES/
RTS4AN3O 
January 06, 2022 
Robert Ford, president and CEO of Abbott Laboratories, talks about the company’s Lingo brand of bio-wearable... 
Las Vegas, UNITED STATES 
CES 2022 in Las Vegas 
Robert Ford, president and CEO of Abbott Laboratories, talks about the company’s Lingo brand of bio-wearable devices during a keynote address at CES 2022 in Las Vegas, Nevada, U.S. January 6, 2022. REUTERS/Steve Marcus 
HEALTH-CORONAVIRUS/GERMANY-VACCINATIONS
RTS45RZJ 
January 01, 2022 
A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19)... 
Berlin, Germany 
COVID-19 vaccination continues on the first day of 2022, in Berlin 
A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi 
COLOMBIA-CRYPTOCURRENCY/BEETLES
RTXJIEEY 
October 08, 2021 
German Viasus Tibamoso, founder of Tierra Viva, waits for a truck loaded with organic waste that will... 
Tunja, Colombia 
German Viasus Tibamoso, founder of Tierra Viva, waits for a truck loaded with organic waste that will... 
German Viasus Tibamoso, founder of Tierra Viva, waits for a truck loaded with organic waste that will later be used to produce bio-compost and biofertilizer with the help of beetle larvae, in a production plant, in Tunja, Colombia, October 8, 2021. Picture taken October 8, 2021. REUTERS/Luisa Gonzalez 
COLOMBIA-CRYPTOCURRENCY/BEETLES
RTXJIEER 
October 08, 2021 
Beetle larvae are seen on organic waste covered with soil to produce bio-compost, at Tierra Viva's production... 
Tunja, Colombia 
Beetle larvae are seen on organic waste covered with soil to produce bio-compost, at Tierra Viva's production... 
Beetle larvae are seen on organic waste covered with soil to produce bio-compost, at Tierra Viva's production plant, in Tunja, Colombia, October 8, 2021. Picture taken October 8, 2021. REUTERS/Luisa Gonzalez 
COLOMBIA-CRYPTOCURRENCY/BEETLES
RTXJIEEO 
October 08, 2021 
A Tierra Viva worker excavates organic waste that will later be used to produce bio-compost and bio-fertilizer... 
Tunja, Colombia 
A Tierra Viva worker excavates organic waste that will later be used to produce bio-compost and bio-fertilizer... 
A Tierra Viva worker excavates organic waste that will later be used to produce bio-compost and bio-fertilizer with the help of beetle larvae at a production plant in Tunja, Colombia, October 8, 2021. Picture taken October 8, 2021. REUTERS/Luisa Gonzalez 
COLOMBIA-CRYPTOCURRENCY/BEETLES
RTXJIEEQ 
October 08, 2021 
Organic waste that will later be used to produce bio-compost and bio-fertilizer with the help of beetle... 
Tunja, Colombia 
Organic waste that will later be used to produce bio-compost and bio-fertilizer with the help of beetle... 
Organic waste that will later be used to produce bio-compost and bio-fertilizer with the help of beetle larvae collected by Tierra Viva is seen in its compost production plant in Tunja, Colombia, October 8, 2021. Picture taken October 8, 2021. REUTERS/Luisa Gonzalez 
COLOMBIA-CRYPTOCURRENCY/BEETLES
RTXJIECB 
October 08, 2021 
Beetles, which are sold as pets to several countries around the world and traded with the Kmushicoin... 
Tunja, Colombia 
Beetles climb a trunk at Tierra Viva's production plant in Tunja 
Beetles, which are sold as pets to several countries around the world and traded with the Kmushicoin cryptocurrency created by Tierra Viva, climb a trunk at the company's production plant, where bio-compost and bio-fertilizer are produced, in Tunja, Colombia, October 8, 2021. Picture taken October 8, 2021. REUTERS/Luisa Gonzalez 
COLOMBIA-CRYPTOCURRENCY/BEETLES
RTXJIECD 
October 08, 2021 
Beetles, which are sold as pets to several countries around the world and traded with the Kmushicoin... 
Tunja, Colombia 
Beetles climb a trunk at Tierra Viva's production plant in Tunja 
Beetles, which are sold as pets to several countries around the world and traded with the Kmushicoin cryptocurrency created by Tierra Viva, climb a trunk at the company's production plant, where bio-compost and bio-fertilizer are produced, in Tunja, Colombia, October 8, 2021. Picture taken October 8, 2021. REUTERS/Luisa Gonzalez 
USA-TRADE/EU
RTXHXHSD 
September 30, 2021 
U.S. ecretary of State Antony Blinken gestures to researchers working in bio-containment laboratories... 
Pittsburgh, UNITED STATES 
U.S. State Secretary Antony Blinken visits Argo AI, in Pittsburgh 
U.S. ecretary of State Antony Blinken gestures to researchers working in bio-containment laboratories for highly infectious pathogens as he is escorted by Paul Duprex, PhD, director of University of Pittsburgh’s Center for Vaccine Research, on a tour at the ARGO facility during a meeting of the United States-European Union Trade and Technology Council (TTC), in Pittsburgh, Pennsylvania, U.S., September 30, 2021. Rebecca Droke/Pool via REUTERS 
USA-FUNDS/SALT
RTXH4AMH 
September 13, 2021 
Dina Radenkovic, Partner at the SALT Bio Fund and Chief Science Officer of the Hooke longevity clinic,... 
New York, UNITED STATES 
Dina Radenkovic, Partner at the SALT Bio Fund and Chief Science Officer of the Hooke longevity clinic,... 
Dina Radenkovic, Partner at the SALT Bio Fund and Chief Science Officer of the Hooke longevity clinic, speaks during the Skybridge Capital SALT New York 2021 conference in New York City, U.S., September 13, 2021. REUTERS/Brendan McDermid 
HEALTH-MALARIA/BIONTECH
RTXGA3P6 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9XDD 
August 27, 2021 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen pose for a family photo with Rwanda's President Paul Kagame and Senegal's President Macky Sall in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9X5C 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin attends a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin attends a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9WIS 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9WJ0 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9W4G 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin speaks next to European Commission President Ursula von der... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin speaks next to European Commission President Ursula von der Leyen during a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9W4H 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen wear... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen wear face masks during a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9W4F 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9VRA 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen attend a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9VOS 
August 27, 2021 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen bump... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen bump fists during a meeting in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9V81 
August 27, 2021 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen meet with Rwanda's President Paul Kagame and Senegal's President Macky Sall in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9V7Z 
August 27, 2021 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen meet with Rwanda's President Paul Kagame and Senegal's President Macky Sall in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-MALARIA/BIONTECH
RTXG9UZ0 
August 27, 2021 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission... 
Berlin, Germany 
G20 Compact with Africa meeting in Berlin 
CEO of kENUP Foundation, Holm Keller, CEO and co-founder of BioNTech, Ugur Sahin and European Commission President Ursula von der Leyen meet with Rwanda's President Paul Kagame and Senegal's President Macky Sall in Berlin, Germany, August 27, 2021. REUTERS/Michele Tantussi 
HEALTH-CORONAVIRUS/GERMANY-VACCINATION
RTXG9RWQ 
August 27, 2021 
A medical worker in a school hall administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a student... 
Dusseldorf, Germany 
Students of the Leibniz-Montessori secondary school receive a COVID-19 vaccine in Dusseldorf 
A medical worker in a school hall administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a student of the Leibniz-Montessori secondary school, amid the coronavirus disease (COVID-19) pandemic, in Dusseldorf, Germany, August 27, 2021. REUTERS/Thilo Schmuelgen 
HEALTH-CORONAVIRUS/GERMANY-VACCINATION
RTXG9RT5 
August 27, 2021 
A medical worker in a school hall administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a student... 
Dusseldorf, Germany 
Students of the Leibniz-Montessori secondary school receive a COVID-19 vaccine in Dusseldorf 
A medical worker in a school hall administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a student of the Leibniz-Montessori secondary school, amid the coronavirus disease (COVID-19) pandemic, in Dusseldorf, Germany, August 27, 2021. REUTERS/Thilo Schmuelgen 
HEALTH-CORONAVIRUS/GERMANY-VACCINATION
RTXG9RT1 
August 27, 2021 
A medical worker in a school hall administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a student... 
Dusseldorf, Germany 
Students of the Leibniz-Montessori secondary school receive a COVID-19 vaccine in Dusseldorf 
A medical worker in a school hall administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a student of the Leibniz-Montessori secondary school, amid the coronavirus disease (COVID-19) pandemic, in Dusseldorf, Germany, August 27, 2021. REUTERS/Thilo Schmuelgen 
GERMANY-POLITICS/MERKEL
RTXFVMD9 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech, Oliver... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech, Oliver Hennig, Senior Vice President Operations and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVM9I 
August 19, 2021 
CEO and co-founder of BioNTech, Ugur Sahin welcomes German Chancellor Angela Merkel before a visit of... 
Marburg, Germany 
German Chancellor Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg 
CEO and co-founder of BioNTech, Ugur Sahin welcomes German Chancellor Angela Merkel before a visit of the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVM9H 
August 19, 2021 
CEO and co-founder of BioNTech, Ugur Sahin welcomes German Chancellor Angela Merkel before a visit of... 
Marburg, Germany 
German Chancellor Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg 
CEO and co-founder of BioNTech, Ugur Sahin welcomes German Chancellor Angela Merkel before a visit of the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVM9J 
August 19, 2021 
CEO and co-founder of BioNTech, Ugur Sahin welcomes German Chancellor Angela Merkel before a visit of... 
Marburg, Germany 
German Chancellor Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg 
CEO and co-founder of BioNTech, Ugur Sahin welcomes German Chancellor Angela Merkel before a visit of the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVM2W 
August 19, 2021 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg,... 
Marburg, Germany 
German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg... 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVM2Y 
August 19, 2021 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg,... 
Marburg, Germany 
German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg... 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVM2X 
August 19, 2021 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg,... 
Marburg, Germany 
German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg... 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLYI 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech wait for... 
Marburg, Germany 
German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech wait for the arrival of German Chancellor Angela Merkel before a visit of the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLYJ 
August 19, 2021 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg,... 
Marburg, Germany 
German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg... 
German Chancellor Angela Merkel visits the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLUS 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech, German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech, German Chancellor Angela Merkel and Helge Braun visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLPQ 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLM7 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLM4 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLIH 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLIG 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
GERMANY-POLITICS/MERKEL
RTXFVLII 
August 19, 2021 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German... 
Marburg, Germany 
Ozlem Tureci and Ugur Sahin, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit... 
Ozlem Tureci and her husband Ugur Sahin, both German scientists, CEOs and founders of BioNTech and German Chancellor Angela Merkel visit the BioNTech COVID-19 mRNA vaccine production facility in Marburg, Germany, August 19, 2021. Arne Dedert/Pool via Reuters 
Sort by 
Display 
Items per page 
Page 
of 14